Agiliti Unveils New Adapt Line™ of Therapeutic Support Surfaces for Enhanced Comfort and Outcomes

Agiliti, a leading provider of medical device solutions, has announced the launch of its new Adapt Line™ of therapeutic hospital support surfaces. These surfaces are clinically designed to improve patient comfort and reduce the risk of pressure injuries caused by…

Read MoreAgiliti Unveils New Adapt Line™ of Therapeutic Support Surfaces for Enhanced Comfort and Outcomes

Flatiron Health to Present Research at San Antonio Breast Cancer Symposium 2024

Flatiron Health today announced its participation in the upcoming San Antonio Breast Cancer Symposium (SABCS), with four accepted abstracts for poster presentation. Additionally, the company will sponsor a session titled “How Holistic Real-World Evidence Generation Advances Breast Cancer Research.” “We…

Read MoreFlatiron Health to Present Research at San Antonio Breast Cancer Symposium 2024

Carlsmed Receives FDA Clearance for aprevo® Cervical Fusion Device

Carlsmed, Inc., a MedTech company specializing in AI-driven personalized spine surgery, today announced that it has received FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This achievement highlights Carlsmed’s dedication to advancing patient-specific spine surgery solutions aimed at…

Read MoreCarlsmed Receives FDA Clearance for aprevo® Cervical Fusion Device

Covenant Behavioral Health Gets Grant to Enhance ADHD Care for Military Families

Covenant Behavioral Health, a leading healthcare provider for active-duty personnel, veterans, and their families, has received the inaugural grant from Qbtech’s new QbAccess program. This initiative is designed to offer non-profit healthcare organizations access to Qbtech’s FDA-cleared objective ADHD testing…

Read MoreCovenant Behavioral Health Gets Grant to Enhance ADHD Care for Military Families

UK MHRA Grants Innovation Passport to ILiAD Biotech’s BPZE1 Intranasal Pertussis Vaccine

ILiAD Biotechnologies, a clinical-stage biotech company focused on preventing and treating diseases caused by Bordetella pertussis and other respiratory pathogens, announced that the U.K. Medicines & Healthcare Products Regulatory Agency (MHRA) has granted its BPZE1 next-generation intranasal pertussis vaccine the…

Read MoreUK MHRA Grants Innovation Passport to ILiAD Biotech’s BPZE1 Intranasal Pertussis Vaccine

Reveal Genomics and IEO Collaborate on HER2DX® Test Decision-Making Study

Reveal Genomics, a Barcelona-based biotechnology startup focused on revolutionizing precision oncology through biomarker innovation, has partnered with the European Institute of Oncology (IEO) to launch a groundbreaking impact study on HER2DX®, the world’s first specialized genomic test for HER2+ breast…

Read MoreReveal Genomics and IEO Collaborate on HER2DX® Test Decision-Making Study